| Target Price | $2,891.70 |
| Price | $2,139.56 |
| Potential | 35.15% |
| Number of Estimates | 27 |
| 27 Analysts have issued a price target MercadoLibre 2026 . The average MercadoLibre target price is $2,891.70. This is 35.15% higher than the current stock price. The highest price target is $3,675.00 71.76% , the lowest is $2,070.50 3.23% . | |
| A rating was issued by 31 analysts: 28 Analysts recommend MercadoLibre to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the MercadoLibre stock has an average upside potential 2026 of 35.15% . Most analysts recommend the MercadoLibre stock at Purchase. |
27 Analysts have issued a sales forecast MercadoLibre 2025 . The average MercadoLibre sales estimate is $28.9b . This is 10.30% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $30.7b 17.35% , the lowest is $27.3b 4.11% .
This results in the following potential growth metrics:
| 2024 | $20.8b | 37.53% |
|---|---|---|
| 2025 | $28.9b | 39.06% |
| 2026 | $36.7b | 26.91% |
| 2027 | $44.6b | 21.62% |
| 2028 | $53.7b | 20.43% |
| 2029 | $62.2b | 15.84% |
| 2030 | $69.3b | 11.33% |
| 2031 | $74.8b | 8.01% |
| 2032 | $83.4b | 11.48% |
27 Analysts have issued an MercadoLibre EBITDA forecast 2025. The average MercadoLibre EBITDA estimate is $4.3b . This is 11.88% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $5.2b 34.45% , the lowest is $3.9b 0.03% .
This results in the following potential growth metrics and future EBITDA Margins:
| 2024 | $2.9b | 18.77% |
|---|---|---|
| 2025 | $4.3b | 47.85% |
| 2026 | $5.8b | 33.36% |
| 2027 | $7.6b | 31.00% |
| 2028 | $9.4b | 24.80% |
| 2029 | $11.6b | 23.13% |
| 2030 | $13.8b | 18.77% |
| 2031 | $14.3b | 3.60% |
| 2032 | $16.3b | 14.38% |
| 2024 | 14.07% | 13.65% |
|---|---|---|
| 2025 | 14.96% | 6.30% |
| 2026 | 15.72% | 5.08% |
| 2027 | 16.94% | 7.76% |
| 2028 | 17.55% | 3.60% |
| 2029 | 18.65% | 6.27% |
| 2030 | 19.90% | 6.70% |
| 2031 | 19.09% | 4.07% |
| 2032 | 19.59% | 2.62% |
24 MercadoLibre Analysts have issued a net profit forecast 2025. The average MercadoLibre net profit estimate is $2.3b . This is 8.41% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $3.0b 44.41% , the lowest is $1.9b 7.63% .
This results in the following potential growth metrics and future Net Margins:
| 2024 | $1.9b | 93.62% |
|---|---|---|
| 2025 | $2.3b | 17.83% |
| 2026 | $3.3b | 46.83% |
| 2027 | $4.5b | 37.02% |
| 2028 | $6.1b | 34.60% |
| 2029 | $7.8b | 28.26% |
| 2030 | $9.8b | 24.69% |
| 2031 | $11.2b | 14.93% |
| 2032 | $13.9b | 23.57% |
| 2024 | 9.20% | 40.78% |
|---|---|---|
| 2025 | 7.79% | 15.30% |
| 2026 | 9.02% | 15.79% |
| 2027 | 10.16% | 12.64% |
| 2028 | 11.36% | 11.81% |
| 2029 | 12.57% | 10.65% |
| 2030 | 14.08% | 12.01% |
| 2031 | 14.98% | 6.39% |
| 2032 | 16.61% | 10.88% |
24 Analysts have issued a MercadoLibre forecast for earnings per share. The average MercadoLibre EPS is $44.62 . This is 8.94% higher than earnings per share in the financial year 2024. The highest EPS forecast is $59.43 45.09% , the lowest is $38.01 7.20% .
This results in the following potential growth metrics and future valuations:
| 2024 | $37.69 | 94.78% |
|---|---|---|
| 2025 | $44.62 | 18.39% |
| 2026 | $65.51 | 46.82% |
| 2027 | $89.77 | 37.03% |
| 2028 | $120.83 | 34.60% |
| 2029 | $154.97 | 28.25% |
| 2030 | $193.24 | 24.70% |
| 2031 | $222.08 | 14.92% |
| 2032 | $274.43 | 23.57% |
| Current | 51.75 | 26.12% |
|---|---|---|
| 2025 | 47.51 | 8.20% |
| 2026 | 32.36 | 31.89% |
| 2027 | 23.61 | 27.04% |
| 2028 | 17.54 | 25.71% |
| 2029 | 13.68 | 22.01% |
| 2030 | 10.97 | 19.81% |
| 2031 | 9.55 | 12.94% |
| 2032 | 7.72 | 19.16% |
Based on analysts' sales estimates for 2025, the MercadoLibre stock is valued at an EV/Sales of 3.77 and an P/S ratio of 3.72 .
This results in the following potential growth metrics and future valuations:
| Current | 4.16 | 19.85% |
|---|---|---|
| 2025 | 3.77 | 9.30% |
| 2026 | 2.97 | 21.21% |
| 2027 | 2.44 | 17.77% |
| 2028 | 2.03 | 16.96% |
| 2029 | 1.75 | 13.68% |
| 2030 | 1.57 | 10.18% |
| 2031 | 1.46 | 7.41% |
| 2032 | 1.31 | 10.30% |
| Current | 4.10 | 22.02% |
|---|---|---|
| 2025 | 3.72 | 9.34% |
| 2026 | 2.93 | 21.21% |
| 2027 | 2.41 | 17.77% |
| 2028 | 2.00 | 16.97% |
| 2029 | 1.73 | 13.67% |
| 2030 | 1.55 | 10.18% |
| 2031 | 1.44 | 7.41% |
| 2032 | 1.29 | 10.30% |
| Analyst | Rating | Action | Date |
|---|---|---|---|
| UBS |
Buy
➜
Buy
|
Unchanged | Nov 24 2025 |
| BTIG |
Buy
➜
Buy
|
Unchanged | Nov 14 2025 |
| Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Nov 03 2025 |
| JP Morgan |
Neutral
➜
Neutral
|
Unchanged | Nov 03 2025 |
| Barclays |
Overweight
➜
Overweight
|
Unchanged | Oct 30 2025 |
| Cantor Fitzgerald |
Overweight
➜
Overweight
|
Unchanged | Oct 30 2025 |
| Benchmark |
Buy
➜
Buy
|
Unchanged | Oct 30 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
UBS:
Buy
➜
Buy
|
Nov 24 2025 |
|
Unchanged
BTIG:
Buy
➜
Buy
|
Nov 14 2025 |
|
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Nov 03 2025 |
|
Unchanged
JP Morgan:
Neutral
➜
Neutral
|
Nov 03 2025 |
|
Unchanged
Barclays:
Overweight
➜
Overweight
|
Oct 30 2025 |
|
Unchanged
Cantor Fitzgerald:
Overweight
➜
Overweight
|
Oct 30 2025 |
|
Unchanged
Benchmark:
Buy
➜
Buy
|
Oct 30 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


